FDA Determines Regulatory Review Period for TALENT ABDOMINAL STENT GRAFT SYSTEM Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the TALENT ABDOMINAL STENT GRAFT SYSTEM, a medical device, in order to extend its patent protection as required by law.